BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33491970)

  • 1. Long noncoding RNA KTN1 antisense RNA 1exerts an oncogenic function in lung adenocarcinoma by regulating DEP domain containing 1 expression via activating epithelial-mesenchymal transition.
    Li YY; Li W; Chang GZ; Li YM
    Anticancer Drugs; 2021 Jun; 32(6):614-625. PubMed ID: 33491970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
    Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
    Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA ROR1-AS1 enhances lung adenocarcinoma metastasis and induces epithelial-mesenchymal transition by sponging miR-375.
    Xu N; Qiao L; Yin L; Li H
    J BUON; 2019; 24(6):2273-2279. PubMed ID: 31983094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA KTN1-AS1 promotes the progression of non-small cell lung cancer via sponging of miR-130a-5p and activation of PDPK1.
    Li C; Zhao W; Pan X; Li X; Yan F; Liu S; Feng J; Lu J
    Oncogene; 2020 Sep; 39(39):6157-6171. PubMed ID: 32820252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis.
    Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A
    J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.
    Han S; Cao D; Sha J; Zhu X; Chen D
    Mol Oncol; 2020 May; 14(5):1074-1088. PubMed ID: 31919993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long noncoding RNA KTN1-AS1 promotes bladder cancer tumorigenesis via KTN1 cis-activation and the consequent initiation of Rho GTPase-mediated signaling.
    Hu X; Xiang L; He D; Zhu R; Fang J; Wang Z; Cao K
    Clin Sci (Lond); 2021 Feb; 135(3):555-574. PubMed ID: 33480975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6-methyladenosine-induced SVIL antisense RNA 1 restrains lung adenocarcinoma cell proliferation by destabilizing E2F1.
    Hu Z; Zhu L; Zhang Y; Chen B
    Bioengineered; 2022 Feb; 13(2):3093-3107. PubMed ID: 35068325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA
    Xu W; Wang J; Xu J; Li S; Zhang R; Shen C; Xie M; Zheng B; Gu M
    J Int Med Res; 2022 Apr; 50(4):3000605221093135. PubMed ID: 35466755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IncRNA KTN1-AS1 Silencing Inhibits Non-Small-Cell Lung Cancer Cell Proliferation and KTN1-AS1 Expression Predicts Survival.
    Wu F; Wang L; Xu L; Song S; Liang M
    Crit Rev Eukaryot Gene Expr; 2022; 32(2):39-46. PubMed ID: 35381130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.
    Liu J; Pan C; Lu R; Zhang S
    Bioengineered; 2022 Mar; 13(3):7868-7880. PubMed ID: 35291911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of lncRNA A2M-AS1 inhibits cell growth and aggressiveness
    Guo H; Li T; Peng C; Mao Q; Shen B; Shi M; Lu H; Xiao T; Yang A; Liu Y
    Hum Exp Toxicol; 2022; 41():9603271221138971. PubMed ID: 36461613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA PCBP1-AS1 correlated with the functional states of cancer cells and inhibited lung adenocarcinoma metastasis by suppressing the EMT progression.
    Li Z; Pan C; Wang Z; Deng X; Zhu Q; Wu W; Chen L
    Carcinogenesis; 2021 Jul; 42(7):931-939. PubMed ID: 34107009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KTN1-AS1, a SOX2-mediated lncRNA, activates epithelial-mesenchymal transition process in esophageal squamous cell carcinoma.
    Chen L; Lu J; Xu T; Yan Z; Guo Y; Dong Z; Guo W
    Sci Rep; 2022 Nov; 12(1):20186. PubMed ID: 36418920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DEPDC1 is Highly Expressed in Lung Adenocarcinoma and Promotes Tumor Cell Proliferation].
    Shen J; Xi M
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):453-460. PubMed ID: 34134185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells.
    Kang H; Ma D; Zhang J; Zhao J; Yang M
    BMC Pulm Med; 2021 May; 21(1):166. PubMed ID: 33992085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.
    Jia Y; Duan Y; Liu T; Wang X; Lv W; Wang M; Wang J; Liu L
    Cell Death Dis; 2019 Jul; 10(8):573. PubMed ID: 31363080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
    Zhang ZB; Liu N
    Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression.
    Ying K; Wang L; Long G; Lian C; Chen Z; Lin W
    Cell Biol Int; 2020 Dec; 44(12):2438-2449. PubMed ID: 32808728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding antisense RNA FAM83A-AS1 promotes lung cancer cell progression by increasing FAM83A.
    Shi R; Jiao Z; Yu A; Wang T
    J Cell Biochem; 2019 Jun; 120(6):10505-10512. PubMed ID: 30659636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.